Surgical Innovations Group PLC 3-year Exclusive UK distribution agreement (9375S)
22 March 2021 - 6:00PM
UK Regulatory
TIDMSUN
RNS Number : 9375S
Surgical Innovations Group PLC
22 March 2021
Surgical Innovations Group plc
("Surgical Innovations", "SI" or the "Company")
3-year Exclusive UK distribution agreement
Elemental Healthcare Ltd sign an extended 3-year exclusive GB
Distribution agreement
with Microline Surgical Inc.
Surgical Innovations Group plc (AIM: SUN), the designer,
manufacturer and distributor of innovative medical technology for
minimally invasive surgery ("MIS"), announces that its wholly owned
subsidiary, Elemental Healthcare Ltd ("Elemental") has signed an
additional three-year exclusive GB distribution agreement with
Microline Surgical Inc. ("Microline") for the distribution in Great
Britain of Microline instruments.
B ased near Boston, MA, U.S.A. Microline designs, manufactures
and distributes high quality instruments aimed at the MIS market.
Its portfolio of products is complementary to those offered by SI
with a focus on the Resposable (TM) ethos of cost and
sustainability. Elemental has a long established relationship with
Microline, and recently announced a new 5-year USA distribution
agreement with Microline for the Company's range of
YelloPort+Plus(TM) and YelloPort Elite(TM) Access Devices..
Adam Power, Surgical Innovations Group Development Director,
says: "We are very pleased to announce an exclusive agreement for a
further three years to sell products manufactured by Microline
Surgical. Microline is Elemental Healthcare's longest standing
distribution partner as well as our largest, and shares the
philosophy of sustainability in its products which will play such
an important part in hospital decision-making in the years to
come."
Isabelle Huysmans, General Manager Microline BV commented: "We
are extremely happy to confirm the extension of the exclusive
agreement for the next three years with our trusted partner,
Elemental Healthcare, who embrace and embody our vision and values
completely. Together we will continue to work passionately on
sustainability to provide solutions to improve the quality of life
for everyone. "
For further information please contact:
Surgical Innovations Group plc www sigroupplc com
David Marsh, CEO Tel: 0113 230 7597
Charmaine Day, Co Sec & GFC
N+1 Singer (Nominated Adviser Tel: 020 7496 3000
& Broker)
Aubrey Powell / Rachel Hayes/
Iqra Amin
Walbrook PR (Financial PR & Investor Tel: 020 7933 8780 or si@walbrookpr.com
Relations)
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584 391
303
About Surgical Innovations Group plc
The Group specialises in the design, manufacture, sale and
distribution of innovative, high quality medical products,
primarily for use in minimally invasive surgery. Our product and
business development is guided and supported by a key group of
nationally and internationally renowned surgeons across the
spectrum of minimally invasive surgical activity.
We design and manufacture and source our branded port access
systems, surgical instruments and retraction devices which are sold
directly in the UK home market through our subsidiary, Elemental
Healthcare, and exported widely through a global network of trusted
distribution partners. Many of our products in this field are based
on a "resposable" concept, in which the products are part
re-usable, part disposable, offering a high quality and
environmentally responsible solution at a cost that is competitive
against fully disposable alternatives.
Elemental also has exclusive UK distribution for a select group
of specialist products employed in laparoscopy, bariatric and
metabolic surgery, hernia repair and breast reconstruction.
In addition, we design and develop medical devices for carefully
selected OEM partners, and have also collaborated with a major UK
industrial partner to provide precision engineering solutions to
complex problems outside the medical arena.
We aim for our brands to be recognised and respected by
healthcare professionals in all major geographical markets in which
we operate and provide by development, partnership or acquisition a
broad portfolio of cost effective, procedure specific surgical
instruments and implantable devices that offer reliable solutions
to genuine clinical needs in the operating theatre environment.
The Group currently employs approximately 100 people across two
sites in the UK. Product design, engineering and manufacturing are
carried out at the SI site in Yorkshire. Commercial activities
including marketing, UK distribution and international sales and
marketing are based at Elemental Healthcare in Berkshire.
Further information
Further details of the Group's businesses and products are
available on the following websites:
www sigroupplc com
www surginno com
www elementalhealthcare co.uk
To receive regular updates by email, please contact
si@walbrookpr.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCDKCBPCBKDCND
(END) Dow Jones Newswires
March 22, 2021 03:00 ET (07:00 GMT)
Surgical Innovations (LSE:SUN)
Historical Stock Chart
From Jan 2025 to Feb 2025
Surgical Innovations (LSE:SUN)
Historical Stock Chart
From Feb 2024 to Feb 2025
